Valuation : Healthconn Corp.

Market Cap 798M 25.23M 21.71M 20.42M 18.66M 34.9M 2.38B 35M 241M 93.66M 1.22B 94.73M 92.67M 3.94B P/E 2024
43.8x
P/E 2025 108x
Enterprise Value 679M 21.46M 18.47M 17.37M 15.87M 29.69M 2.03B 29.77M 205M 79.67M 1.04B 80.58M 78.83M 3.35B EV / Sales 2024
0.41x
EV / Sales 2025 0.7x
Free-Float
58.01%
Yield 2024
3.81%
Yield 2025 0.74%
1 day-2.22%
1 week-6.63%
Current month-2.22%
1 month-3.03%
3 months-7.85%
6 months-14.56%
Current year-12.22%
1 week 17.2
Extreme 17.2
18.85
1 month 17.2
Extreme 17.2
19.4
Current year 17.2
Extreme 17.2
24.4
1 year 17.2
Extreme 17.2
25
3 years 16.9
Extreme 16.9
31.25
5 years 16.9
Extreme 16.9
54.6
10 years 16.9
Extreme 16.9
247.02
Manager TitleAgeSince
Chief Executive Officer - 21/12/2023
Director of Finance/CFO - 21/12/2018
Comptroller/Controller/Auditor - 22/03/2021
Director TitleAgeSince
Director/Board Member - 27/12/2017
Director/Board Member - 22/06/2020
Director/Board Member - 17/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.22%-6.63%-23.81%-42.30% 25.23M
+0.08%+1.95%-14.89%-27.07% 190M
+0.58%-0.19%-47.70%-53.47% 160M
Average -0.52%+0.43%-28.80%-40.94% 125.23M
Weighted average by Cap. +0.14%+1.50%-29.49%-39.35%

Financials

2024 2025
Net sales 1.25B 39.61M 34.09M 32.07M 29.3M 54.81M 3.74B 54.96M 379M 147M 1.92B 149M 146M 6.18B 1.13B 35.75M 30.76M 28.94M 26.44M 49.46M 3.38B 49.59M 342M 133M 1.73B 134M 131M 5.58B
Net income 19.23M 608K 523K 492K 449K 841K 57.38M 843K 5.81M 2.26M 29.44M 2.28M 2.23M 94.84M 8.39M 265K 228K 215K 196K 367K 25.05M 368K 2.54M 985K 12.85M 996K 975K 41.4M
Net Debt -317M -10.03M -8.63M -8.12M -7.42M -13.88M -947M -13.92M -96M -37.25M -486M -37.68M -36.86M -1.57B -119M -3.77M -3.24M -3.05M -2.79M -5.21M -356M -5.23M -36.05M -13.99M -183M -14.15M -13.84M -588M
Logo Healthconn Corp.
HEALTHCONN CORP. is a Taiwan-based Company mainly engaged in the provision of disease prevention and treatment services. The Company is engaged in the provision of precisely prevent medical integration services, molecular biology testing programs and accurate diagnostic testing services. The precisely prevent medical integration services include precisely prevention, disease management and health promotion services. The molecular bioassay services include food safety testing and functional medical testing services. The accurate diagnostic testing services include molecular testing and clinical microbiological testing services, as well as the development and operation of medical health institutions. The Company is also engaged in the medical equipment sale business. The Company operates in the Taiwan market as well as in the mainland China market.
Employees
205
Date Price Change Volume
04/09/26 NT$17.60 -2.22% 21,050
03/09/26 NT$18.00 +1.69% 14,030
02/09/26 NT$17.70 -2.21% 11,030
01/09/26 NT$18.10 +0.56% 35,116
31/08/26 NT$18.00 -4.51% 25,040
  1. Stock Market
  2. Stocks
  3. 6665 Stock